Medzole-DSR Capsule is a combination pharmaceutical formulation containing Domperidone 30mg and Pantoprazole 40mg, designed to manage gastrointestinal disorders characterized by acid reflux, nausea, and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea and vomiting. Pantoprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. The synergistic action of Domperidone and Pantoprazole in Medzole-DSR Capsule offers comprehensive management of upper gastrointestinal symptoms by addressing both motility and acid secretion abnormalities. This combination is particularly beneficial in patients experiencing reflux esophagitis with associated delayed gastric emptying. Medzole-DSR should be used under medical supervision, with attention to contraindications such as cardiac arrhythmias or hypersensitivity to the components. Adherence to prescribed dosage and monitoring for potential side effects, including headache, dry mouth, or abdominal cramps, is recommended to ensure optimal therapeutic outcomes.